Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution

Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution

Montaño, C., Bendstrup, E., Rønnov-Jessen, I. et al.

ERJ Open Res 2025; 11: 00567-2024
 

Read the publication